baber/WOPTO huggingface dataset:
Patent NZ-532063-A (NZ)
Title: Methods for wet granulating azithromycin
Inventor: FERGIONE MICHAEL BRUCE
IPC: A61K9/26
Filed: 2002-12-09
Abstract: A method of forming non-dihydrate azithromycin granules is described to comprise: a) mixing: (i) non-dihydrate azithromycin particles, (ii) a granulating amount of a non-aqueous granulating liquid, and (iii) optionally, particles of one or more pharmaceutically acceptable excipients, to form wet granules (which comprise non-dihydrate azithromycin and the non-aqueous granulating liquid); and b) drying the wet granules to remove the non- aqueous granulating liquid and thereby form non-dihydrate azithromycin granules. The non-dihydrate azithromycin is selected from the group consisting of azithromycin monohydrate hemi-ethanol solvate, azithromycin monohydrate hemi-n-propanol, azithromycin sesquihydrate and azithromycin monohydrate hemi-isopropanol solvate. Use of the pharmaceutical formulation including granules of non-dihydrate azithromycin is disclosed to be for the preparation of a medicament for treating a bacterial or protozoal infection in a mammal.
Patent NZ-533595-A (NZ)
Title: Methods and products for oral care using metal binding peptides
Inventor: BAR-OR DAVID
Filed: 2002-11-19
Abstract: Disclosed is an oral care product comprising one or more dosages of a peptide present in an amount effective for oral care, wherein a single dosage is less than 100mg of the peptide, and wherein the peptide has the formula: P1 - P2, wherein: P1 is:  Xaa1Xaa2His: or Xaa1Xaa2HisXaa3; P2 is (Xaa4)n; Xaa1is glycine, alanine, valine, leucine, isoleucine, serine, threonine, aspartic acid, isoaspartic acid, asparagine, glutamic acid, isoglutamic acid, glutamine, lysine, hydroxylysine, histidine, arginine, ornithine, phenylalanine, tyrosine, tryptophan, cysteine, methionine, or a-hydroxymethylserine; Xaa2 is glycine, alanine, p-alanine, valine, leucine, isoleucine, serine, threonine, aspartic acid, asparagine, glutamic acid, glutamine, lysine, hydroxylysine, histidine, arginine, ornithine, phenylalanine, tyrosine, tryptophan, cysteine, methionine, or hydroxymethylserine; Xaa3is glycine, alanine, valine, lysine, arginine, ornithine, aspartic acid, glutamic acid, asparagine, glutamine or tryptophan; Xaa4 is any amino acid; and n is 0-10; or a physiologically-acceptable salt thereof. The peptides are metal-binding and can reduce inflammation of tissues of the mouth and can reduce the damage done by reactive oxygen species to such tissues.
Patent NZ-534101-A (NZ)
Title: Cover plate formed from two abutting halves allowing cables to pass through
Inventor: EAGLEN ANDREW RICHARD
Filed: 2004-07-14
Abstract: A cover plate 1 that is used for covering wall cavities and allows the passage of cables is disclosed. The cover plate is formed from two half plates 2, 3 that have interlocking connecting means 5, 6 along their joining edges. At least one of the half plates has a recess 4 formed in the joining edge of a size and shape selected to allow a cable or cables to be located. The plates have means 7 for mounting the joined cover plate to be fixed to a wall.
Patent NZ-536522-A (NZ)
Title: Child-resistant blister pack
Inventor: FRENCH GARY STUART
IPC: A61J1/03
Filed: 2003-05-08
Abstract: The child-resistant blister pack for unit dosage forms (10) has a blister film sheet (12) with depressions (16) therein, unit dosage forms (10) within the depressions (16) and a lidding sheet (14) which overlies the depressions (16) and which is secured to the film sheet (12) so as to seal the unit dosage forms (10) within the depressions (16). A network of lines of weakness in the pack define a plurality of dosage units (18-25, but only 18-21 shown). Each dosage unit includes one of said dosage forms (10) and a peel region (40-47, but only 40-42 shown) where part of the lidding sheet (14) is not secured to the blister film sheet (12). Each peel region is disposed adjacent a respective one of the lines of weakness.
Patent NZ-545741-A (NZ)
Title: Substituted azaindoles as inhibitors of protein kinases, and process for their preparation
Inventor: COX PAUL JOSEPH
IPC: A61P17/02
Filed: 2002-06-20
Abstract: Physiologically active substituted azaindole compounds of general formula (I); compositions containing such compounds; their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs are disclosed, wherein the variables shown in formula (I) are as defined in the specification. Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases, whereby these compounds are suitable for use in the treatment of disease states capable of being modulated by the inhibition of the protein kinases.
Patent NZ-546763-A (NZ)
Title: Computer aided document retrieval
Inventor: PATTERSON DAVID
IPC: G06F17/30
Filed: 2004-09-27
Abstract: A method of determining cluster attractors for a plurality of documents comprising at least one term is disclosed. The method comprises calculating a probability distribution indicative of the frequency of occurrence of the, or each, other term that co-occurs with the term in at least one of the documents for each term. Then, the entropy of the respective probability distribution is calculated. Finally, at least one of the probability distributions is selected as a cluster attractor depending on the respective entropy value. This above described method is used in a method of clustering a plurality of documents. Once the cluster attractions are determined, each document is compared with each cluster attractor and each document is assigned to one or more cluster attractors depending on the similarity between the document and the cluster attractors.
Patent NZ-547314-A (NZ)
Title: Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (CCR-3)
Inventor: MARTYRES DOMNIC
IPC: A61K31/496
Filed: 2004-11-11
Abstract: Disclosed is a compound of formula 1 wherein R1 is optionally substituted phenyl, benzoxazole, benzothiazole or thiazole [5, 4-b] pyridine, wherein B is phenyl and wherein the rest of the substituents are disclosed within the specification. Also disclosed is a process of making a compound of formula 1 and the use of a compound of formula 1 for the preparation of a medicament for the prevention and/or treatment of diseases in which CCR3 activity modulators have a therapeutic benefit.
Patent NZ-550971-A (NZ)
Title: A method of operating a water chiller
Inventor: CHERTKOW BRIAN
IPC: F25B49/02
Filed: 2005-03-15
Abstract: A method of operating a water chiller (10) having a water tank (12), a cold water tap, a condenser and a fan (18) is disclosed. The chiller avoids freezing the water in tank (12) by switching between "normal" and "protection" operating modes. The switching between modes is initially triggered by checking the length of time since the cold water tap was last operated.
Patent NZ-551326-A (NZ)
Title: Gelatine nanoparticles, for use in medicine, and method for the production thereof
Inventor: AHLERS MICHAEL
IPC: A61K9/14
Filed: 2005-08-18
Abstract: Disclosed are nanoparticles of an aqueous gelatin gel with an average diameter of 350nm or less, wherein the polydispersity index of the nanoparticles is no more than 0.15. Also disclosed is a process for the production of the nanoparticles, comprising: a) Production of an aqueous gelatin solution, wherein the proportion of gelatin with a molecular weight of less than 65 kDa, in relation to the total gelatin, is at the most 40 % by weight; b) adjustment of the pH value of the gelatin solution to a value below 7.0; c) precipitation of the gelatin as a result of adding a precipitating agent; and d) separation of the nanoparticles as a result of centrifuging. Also discloses is the use of the nanoparticles in medication.
Patent NZ-551361-A (NZ)
Title: System and method for generating hot water
Inventor: HOOK COLIN DAVID
IPC: F24S10/95
Filed: 2006-11-14
Abstract: A system for heating a liquid, such as water, the system including a collector and a storage tank, wherein the collector and the storage tank are fluidly coupled together via a manifold. The collector includes a plurality of heat pipes which extend into the manifold. Each heat pipe includes an at least partially evacuated tube that houses at least a first portion of a sealed riser therein. Solar energy is absorbed by the heat pipes and passed to liquid in the manifold, which in turn, is passed to the storage tank.
Patent NZ-551721-A (NZ)
Title: Ordering system and method
Inventor: ARYANPAD HOMEIRA
Filed: 2006-11-30
Abstract: A method of on-line ordering a folded-sheet product for manufacture includes a user interacting with a user-interface on a client computer system to input a value for each of one or more geometric parameters for a desired folded-sheet product; processing the values to display, on the client computer system, a graphical representation of the desired folded-sheet product; the user inputting, via the user interface, order information for an order of the desired folded-sheet-product; the client computer system generating an order message that is interpretable by a merchant computer system to output an order including the graphical representation and the order information; communicating the order message to the merchant computer system; and the merchant computer system receiving the order message and interpreting the order message to output the order.
Patent NZ-552210-A (NZ)
Title: Natriuretic compounds, conjugates, and uses thereof
Inventor: JAMES KENNETH D
IPC: C07K16/26
Filed: 2005-05-26
Abstract: Disclosed is a natriuretic compound conjugate comprising: a biologically active natriuretic compound wherein the natriuretic compound is a brain natriuretic peptide (BNP) comprising a natriuretic molecule NPR-A binding site that exhibits NPR-A receptor binding activity and comprises a disulfide loop for binding to the NPR-A receptor, at least one modifying moiety conjugation site, wherein the modifying moiety conjugation site comprises at least one lysine amino acid residue of BNP; and at least one modifying moiety attached to said modifying moiety conjugation site of Formula 1A, wherein C is an alkyl moiety of m carbons, m is between 1 and 20, n is between 1 and 25, and X is selected from -C-, -O-, -C(O)-, -OC(O)-, -NH-, -NHC(O)-, and -C(O)NH-. Also disclosed is the use of the natriuretic compound conjugate for treating an excessive level of extracellular fluid.
Patent NZ-552257-A (NZ)
Title: Retractable covering system
Inventor: ROBINSON MICHAEL
Filed: 2006-12-21
Abstract: A covering system (100) provides a retractable covering for a structure (102) such as a pergola or a veranda. The system has a roof portion (103) that is normally open to the environment, and includes a substantially cylindrical shaft (104) having a central longitudinal axis (106) and a motor (108) with which the cylindrical shaft is engaged such that, in use, the motor is operable to rotate the shaft about the longitudinal axis. The motor is operably engaged with a guide disposed upon or adjacent to the roof portion of the structure, whereby the motor is able to move transversely relative to the roof portion along the guide in a direction perpendicular to the longitudinal axis of the shaft. A web of flexible material (114), a first edge (116) of which is fixed to the structure, has an opposing edge which is fixed to the cylindrical shaft. The covering system has an open position wherein the web of flexible material is unrolled from the shaft to substantially cover the roof portion of the structure, and is operable between the open and closed positions by operation of the motor in corresponding opposed rotational directions.
Patent NZ-553037-A (NZ)
Title: Means and methods for producing a stabilized cell of interest by introducing a nucleic acid into a hematopoietic stem cell
Inventor: SPITS HERGEN
IPC: A01K67/027
Filed: 2005-08-10
Abstract: Disclosed is a method for producing a stabilized immune cell culture, said method comprising the steps: -Providing a hematopoietic stem cell and/or a hematopoietic precurs or cell of said immune cell with a nucleic acid sequence which, when present and expressed in said immune cell, is capable of stabilizing said immune cell; -Providing a non-human animal with said hematopoietic stem cell and/or hematopoietic precursor cell; -Allowing generation of said immune cell in said animal; -Obtaining said immune cell; and -Culturing said immune cell ex-vivo after it has been obtained from said animal, wherein expression of said nucleic acid is at least in part inhibited during in-vivo differentiation of said stem cell and/or precursor cell into said immune cell and wherein expression of said nucleic acid is at least in part induced during the ex-vivo culturing of the immune cells, thereby stabilizing the immune cells, and wherein said hematopoietic stem cell is not obtained from a human embryo.
Patent NZ-570155-A (NZ)
Title: Process for producing shaped bodies from a mixture of particulate natural materials and thermoplastic binder
Inventor: PFAADT MARCUS
IPC: C08L97/02
Filed: 2007-02-06
Abstract: Process for the production of mouldings from a mixture of particulate natural materials and thermoplastic binder without added starch, the mixture being shaped into a moulding with temperature and/or pressure increase, characterized in that the thermoplastic binder is used in the form of a polymer powder composition redispersible in water, containing: one or more polymers, based on one or more monomers from the group consisting of vinyl esters, (meth)acrylates of straight-chain or branched alcohols having 1 to 15 carbon atoms, vinylaromatics, olefins, 1,3-dienes and vinyl halides and optionally 0.1 to 5% by weight based on the total weight of monomer mixture, of auxiliary monomers, one or more protective colloids from the group consisting of partly hydrolysed or completely hydrolysed polyvinyl alcohols, polyvinylpyrrolidones, polyvinyl acetals, celluloses and derivatives thereof, proteins, lignin sulphonates, poly(meth)acrylamide, polyvinylsulphonic acids and the water-soluble. copolymers thereof, melamine formaldehyde sulphonates, naphthalene formaldehyde sulphonates, and 1 to 30% by weight of antiblocking agent, based on the proportion of polymer.
Patent NZ-581992-A (NZ)
Title: Device for filtering trash from a liquid including filter panels and a drum for receiving the liquid
Inventor: DAVIS WILLIAM E
IPC: B01D25/00
Filed: 2008-07-16
Abstract: Disclosed is a filter device for filtering a liquid which includes trash. The device includes a drum (25) for receiving the liquid and trash, and the drum includes at least one drum aperture (105). The device further includes a first pair of filter panels which are adapted for filtering the liquid. The filter panels are spaced apart to form a cavity for receiving the liquid and trash. The device further includes a frame (245) for supporting the filter panels, with the frame coupled to the drum. The frame includes a frame aperture (275) wherein the frame aperture and the cavity form a volume having a cross sectional area sized substantially equal to or greater than the drum aperture and wherein said volume extends to a second pair of filter panels to enable liquid and trash which pass through the drum aperture to also pass through the frame aperture to the second pair of filter panels.
Patent NZ-584635-A (NZ)
Title: Inelastic exercise device with elongate strap movable through loop of anchor that can be attached to structure, typically between door top and jamb, with limits on how far loop can move through loop short of full length between end hand grips
Inventor: HETRICK RANDAL
IPC: A63B21/002
Filed: 2008-09-16
Abstract: An exercise device having many advantageous features is described, including the ability to provide a combination of grips to the user, and the ability to easily mount the device to a wall. The exercise device includes a mechanism that permits a limited range of longitudinally motion for an elongated member having grips. The mechanism permits a user to balance while exercising, and provides support resulting from excessive motion of the exercise device. There is typically provided a limiting device in the form of a loop attached to the elongated member and which a support of the anchor passes through that limits travel of the distance of the grips from the anchor.
Patent NZ-586941-A (NZ)
Title: Fermentation with Pantoea agglomerans
Inventor: SOMA GEN-ICHIRO
IPC: A23L11/00
Filed: 2004-09-22
Abstract: Disclosed is a fermentation and culture method comprising fermenting wheat flour, bean curd, rice powder or brown seaweed mekabu with an isolated culture of Pantoea agglomerans.
Patent NZ-587482-A (NZ)
Title: Device for feeding animals including means of restricting the space in which the feed can be accessed
Inventor: PASTOOR JAN LAMBERTUS
IPC: A01K1/00
Filed: 2009-04-09
Abstract: Disclosed is a device (1) for feeding animals. The device has a frame with a feed holder (3) for a feeding site for an animal. The frame is provided with a restricting device with restricting means (7a, 7b) for restricting in at least two opposite lateral directions a dwelling space (5) for an animal using the feeding site. The device also has means (8a, 8b) for keeping animals located outside the dwelling space at a distance from the restricting means.
Patent NZ-592328-A (NZ)
Title: Hydrophobically modified poly(aminoamides) useful in papermaking processes
Inventor: GU QU-MING
IPC: C08G73/02
Filed: 2009-11-18
Abstract: 592328 Disclosed is a water soluble, cationic polymer comprising randomly distributed units of formula (I), wherein X on said unit of formula (I) is a moiety selected from the group consisting of moieties of formulae (II), (III), (IV), (VII) and (VIII), wherein the substituents of each are as described within the specification. Further disclosed is a process for preparing said polymer, and the use of said polymer at any stage of a pulp or papermaking process.
Patent NZ-599810-A (NZ)
Title: Apparatus for singularizing and separating vegetable products
Inventor: BENEDETTI LUCA
IPC: A23N15/02
Filed: 2011-07-21
Abstract: 599810 Apparatus for the singularization and the separation of vegetable products, especially cherries, comprises a conveying and singularization line for the products. The line is defined in a "V" slot 1 having rectilinear configuration, having a body 2 solid with the frame of the apparatus, and delimited by two opposed walls inclined to each other, the slot 1 being provided with two first motorized belts 3A arranged on the opposed walls and placed on the bottom of the slot and driven with synchronous motion in a direction parallel to the slot 1. The slot is further provided with separation means capable of separating two or more the vegetable products connected to each other with respective stalks, and which includes one or more cutting means placed on a side. The cutting means comprise at least a circular blade 5 that rotates around a respective axis which lays on a plane essentially orthogonal to the direction of the "V" slot. The axis is also able to be arranged on a vertical plane. The two opposed and inclined walls are flat - and are basically joined by their lower edge. The two motorized belts 3A are similarly flat, and are substantially parallel to and adjacent respective flat walls.
Patent NZ-601142-A (NZ)
Title: Composition for improving brain function and method for improving brain function
Inventor: GOTO HIROAKI
IPC: A61K38/00
Filed: 2010-09-09
Abstract: 601142 Discloses the use of a peptide consisting of the amino acid sequence A1-Val-Val-Val-Pro-Pro-Phe-Leu-Gln-Pro-Glu-A2 wherein: A1 is absent or represents any of: Thr-Gln-Thr-Pro; Pro-Leu-Thr-Gln-Thr-Pro; Leu-Thr-Gln-Thr-Pro; Pro; Pro-Pro-Leu-Thr-Gln-Thr-Pro; Ile-Pro-Pro-Leu-Thr-Gln-Thr-Pro; or Asn-Ile-Pro-Pro-Leu-Thr-Gln-Thr-Pro; And A2 is absent or represents Val-Met, in the manufacture of a medicament for improving brain function (such as amnesia), a method of improving brain function in non-humans and the peptide.
Patent NZ-601220-A (NZ)
Title: Hepatitis c virus inhibitors
Inventor: BELEMA MAKONEN
IPC: C07D417/14
Filed: 2010-12-13
Abstract: Disclosed are methyl ((1S)-1-(((2S)-2-(4-(4’-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetyl)-2-pyrrolidinyl)-4-chloro-1H-imidazol-5-yl)-4-biphenylyl)-1H-5-chloro-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate derivatives as represented by the general formula (I) or a pharmaceutically acceptable salt thereof, wherein: n is 0, 1, or 2; X is selected from hydrogen, alkenyl, cyano, cycloalkyl, (cycloalkyl)alkyl, halo, and heterocyclyl; R1 is selected from hydrogen and halo; R2 is selected from hydrogen, alkenyl, cyano, cycloalkyl, (cycloalkyl)alkyl, halo, and heterocyclyl; or R1 and R2, together with the carbon atoms to which they are attached, form a six-membered aromatic ring optionally substituted with one halo group; provided that at least one of X and R2 is selected from alkenyl, cyano, cycloalkyl, (cycloalkyl)alkyl, halo, and heterocyclyl; each R3 is alkyl, wherein the alkyl can optionally form a fused three- or four-membered ring with an adjacent carbon atom or a spirocyclic three- or four-membered ring with the carbon atom to which it is attached; wherein the fused and spirocyclic rings are optionally substituted with one or two alkyl groups; each R4 is independently selected from hydrogen and -C(O)R5; and each R5 is independently selected from alkoxy, alkyl, arylalkoxy, arylalkyl, cycloalkyl, heterocyclyl, heterocyclylalkyl, (NRcRd)alkenyl, and (NRcRd25 )alkyl; and wherein the remaining substituents are as defined herein. Further disclosed is a composition comprising a compound as defined above, or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable carrier, and optionally further comprising at least one additional compound having anti-HCV activity, for treating an HCV infection in a patient.
Patent NZ-601737-A (NZ)
Title: Compositions for targeted delivery of sirna
Inventor: HADWIGER PHILIPP
IPC: A61K31/713
Filed: 2011-02-18
Abstract: Disclosed is a composition for delivering an oligonucleotide to a liver cell in vivo. The composition comprises: an oligonucleotide covalently linked to a hydrophobic group having at least 20 carbon atoms; a reversibly masked and targeted amphipathic membrane active polyamine comprising a terpolymer synthesized from amine-containing monomers, lower hydrophobic group-containing monomers, and higher hydrophobic group-containing monomers to which a plurality of galactose derivatives and PEG groups are individually linked to said membrane active polyamine via pH labile disubstituted maleamic bonds and wherein cleavage of said pH labile disubstituted maleamic bonds yields amine groups thereby generating a membrane active polyamine; and wherein the oligonucleotide is not covalently linked to the amphipathic membrane active polyamine.
Patent NZ-606094-A (NZ)
Title: Flow regulating applied magnetic envelope
Inventor: CABOT DOUGLAS C
IPC: F16L55/1645
Filed: 2011-06-22
Abstract: A flow control method for a flow system such as a pipe 100 or blow-out preventer on the superstructure in the flow system includes applying a magnetic field at a targeted point in the flow system and introducing bridging and obstructing materials to the flow system. The bridging and obstructing materials such as magnetically susceptible bodies are introduced upstream of the targeted point through a manifold 75 and on delivery lines 110 and are captured by the applied magnetic field to create a flow preventing or restriction plug at the targeted point.